NO131422B - - Google Patents
Download PDFInfo
- Publication number
- NO131422B NO131422B NO2054/71A NO205471A NO131422B NO 131422 B NO131422 B NO 131422B NO 2054/71 A NO2054/71 A NO 2054/71A NO 205471 A NO205471 A NO 205471A NO 131422 B NO131422 B NO 131422B
- Authority
- NO
- Norway
- Prior art keywords
- dihydro
- phenyl
- temperature
- benzodiazepine
- mol
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 10
- -1 inorganic acid compound Chemical class 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 239000012429 reaction media Substances 0.000 claims 1
- 230000035484 reaction time Effects 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 39
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 30
- 150000001875 compounds Chemical class 0.000 description 24
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- 235000019441 ethanol Nutrition 0.000 description 18
- 239000000243 solution Substances 0.000 description 14
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 10
- 238000001816 cooling Methods 0.000 description 9
- 238000003756 stirring Methods 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- 230000000704 physical effect Effects 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- YWSOBIMUIPVQQM-UHFFFAOYSA-N 7-chloro-3-ethoxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(OCC)N=C1C1=CC=CC=C1 YWSOBIMUIPVQQM-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 3
- 229910006124 SOCl2 Inorganic materials 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001624 sedative effect Effects 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- QJVOZXGJOGJKPT-IGHBBLSQSA-N (1r,2r,5s,11ar)-2-(prop-2-en-1-yl)-1,2,3,4,5,6,11,11a-octahydro-10h-1,5-methanopyrido[1,2-a][1,5]diazocin-10-one Chemical compound C([C@@H]12)C(=O)C=CN1C[C@@H]1CN[C@H](CC=C)[C@H]2C1 QJVOZXGJOGJKPT-IGHBBLSQSA-N 0.000 description 2
- VYHHZMOFRMSLFY-UHFFFAOYSA-N 7-chloro-3-methoxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(OC)N=C1C1=CC=CC=C1 VYHHZMOFRMSLFY-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229910019213 POCl3 Inorganic materials 0.000 description 2
- QJVOZXGJOGJKPT-UHFFFAOYSA-N albine Natural products C12CC(=O)C=CN2CC2CNC(CC=C)C1C2 QJVOZXGJOGJKPT-UHFFFAOYSA-N 0.000 description 2
- 230000001773 anti-convulsant effect Effects 0.000 description 2
- 239000001961 anticonvulsive agent Substances 0.000 description 2
- 229960003965 antiepileptics Drugs 0.000 description 2
- 229940049706 benzodiazepine Drugs 0.000 description 2
- 150000001557 benzodiazepines Chemical class 0.000 description 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000001003 psychopharmacologic effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- KWGRBVOPPLSCSI-PSASIEDQSA-N (1s,2r)-2-(methylamino)-1-phenylpropan-1-ol Chemical compound CN[C@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-PSASIEDQSA-N 0.000 description 1
- UQZIVIVFXNMLLC-UHFFFAOYSA-N 2h-1,4-benzodiazepine Chemical compound C1C=NC=C2C=CC=CC2=N1 UQZIVIVFXNMLLC-UHFFFAOYSA-N 0.000 description 1
- JFGWMAWFJDEKOI-UHFFFAOYSA-N 3-butoxy-7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(OCCCC)N=C1C1=CC=CC=C1 JFGWMAWFJDEKOI-UHFFFAOYSA-N 0.000 description 1
- XYABSRLLOSFJCZ-UHFFFAOYSA-N 7-bromo-3-ethoxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound C12=CC(Br)=CC=C2NC(=O)C(OCC)N=C1C1=CC=CC=C1 XYABSRLLOSFJCZ-UHFFFAOYSA-N 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 231100000111 LD50 Toxicity 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229960005152 pentetrazol Drugs 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB26506/70A GB1293645A (en) | 1970-06-02 | 1970-06-02 | 3-alkoxy-benzodiazepines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO131422B true NO131422B (cs) | 1975-02-17 |
| NO131422C NO131422C (cs) | 1975-05-28 |
Family
ID=10244737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO2054/71A NO131422C (cs) | 1970-06-02 | 1971-06-01 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3689478A (cs) |
| JP (1) | JPS504677B1 (cs) |
| BE (1) | BE823936Q (cs) |
| CH (1) | CH527205A (cs) |
| DE (1) | DE2127387A1 (cs) |
| ES (1) | ES391817A1 (cs) |
| FR (1) | FR2100714B1 (cs) |
| GB (1) | GB1293645A (cs) |
| NL (1) | NL7107341A (cs) |
| NO (1) | NO131422C (cs) |
| SE (1) | SE362647B (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2701557C2 (ru) * | 2017-11-24 | 2019-09-30 | Общество С Ограниченной Ответственностью "Инновационные Фармакологические Разработки" (Ооо "Ифар") | Производные 1,4-бензодиазепин-2-она и их применение |
-
1970
- 1970-06-02 GB GB26506/70A patent/GB1293645A/en not_active Expired
-
1971
- 1971-05-25 FR FR7118823A patent/FR2100714B1/fr not_active Expired
- 1971-05-27 US US147601A patent/US3689478A/en not_active Expired - Lifetime
- 1971-05-27 NL NL7107341A patent/NL7107341A/xx unknown
- 1971-06-01 NO NO2054/71A patent/NO131422C/no unknown
- 1971-06-01 CH CH794971A patent/CH527205A/fr not_active IP Right Cessation
- 1971-06-01 SE SE07020/71A patent/SE362647B/xx unknown
- 1971-06-01 ES ES391817A patent/ES391817A1/es not_active Expired
- 1971-06-02 DE DE19712127387 patent/DE2127387A1/de active Pending
- 1971-06-02 JP JP46037916A patent/JPS504677B1/ja active Pending
-
1974
- 1974-12-27 BE BE152001A patent/BE823936Q/xx active
Also Published As
| Publication number | Publication date |
|---|---|
| US3689478A (en) | 1972-09-05 |
| FR2100714A1 (cs) | 1972-03-24 |
| FR2100714B1 (cs) | 1974-09-06 |
| DE2127387A1 (de) | 1971-12-09 |
| JPS504677B1 (cs) | 1975-02-22 |
| NO131422C (cs) | 1975-05-28 |
| ES391817A1 (es) | 1973-06-16 |
| BE823936Q (fr) | 1975-04-16 |
| NL7107341A (cs) | 1971-12-06 |
| SE362647B (cs) | 1973-12-17 |
| GB1293645A (en) | 1972-10-18 |
| CH527205A (fr) | 1972-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4110337A (en) | Triazolobenzodiazepines | |
| US2910488A (en) | Aniline derivatives | |
| SU820659A3 (ru) | Способ получени производных 4-амино- 5-АлКилСульфОНилОАНизАМидОВ, иХ СОлЕй,ОКиСЕй, лЕВО- и пРАВОВРАщАющиХизОМЕРОВ /иХ ВАРиАНТы/ | |
| US3679698A (en) | 2-nitroimidazoles | |
| JPS60208982A (ja) | アセチルコリンエステラーゼ抑制特性を有するヒソスチグミン誘導体およびその製造方法 | |
| NO125974B (cs) | ||
| US3624103A (en) | 3-indoleacetohydroxamic acids | |
| Elliott | 126. The stereochemistry of an oxazoline derivative of threonine. Improvement of a recent threonine synthesis | |
| NO158739B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater. | |
| NO131422B (cs) | ||
| KR910008183B1 (ko) | 머캅토-아세트산 및 머캅토프로피온산 아미드 유도체의 제조방법 | |
| US3202699A (en) | Carbobenzoxyglycylamino-benzophenones | |
| NO164167B (no) | Analogifremgangsmaate for fremstilling av derivater av 4-fenylkinazolin. | |
| US3674787A (en) | 2-(alpha-morpholinobenzyl)-anilides | |
| US3405165A (en) | Sulfonic acid compound | |
| FI57589C (fi) | Foerfarande foer framstaellning av blodtrycket saenkande 6-substituerade 3-karbetoksihydrazinopyridaziner | |
| US3564010A (en) | Guanidino ureido and thioureido-delta**1-pyrrolines | |
| US4146713A (en) | Method of preparing 3-morpholino-2-cyanoacrylamide | |
| JPS58188876A (ja) | 抗炎症剤及び抗喘息剤 | |
| DK152501B (da) | Fremgangsmaade til fremstilling af pyrrolooe1,2-aaapyrimidiner eller salte deraf | |
| NO132930B (cs) | ||
| US2723975A (en) | 2, 4-di-piperidino-5-benzylpyrimidine | |
| IE58497B1 (en) | New process for the preparation of derivatives of 4h-1, 2,4-triazole, the new triazoles so obtained, their use as medicaments and the pharmaceutical compositions containing them | |
| NO150280B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 9-aminopyrido(1,2-a)pyrimidinderivater | |
| JPS6388170A (ja) | ３−アリ−ル−２，１−ベンゾイソオキサゾールの酢酸誘導体及びそのエステルならびにアミド |